Campbell & Co Investment Adviser’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-9,292
| Closed | -$430K | – | 1100 |
|
2024
Q3 | $430K | Buy |
+9,292
| New | +$430K | 0.03% | 771 |
|
2024
Q1 | – | Sell |
-32,578
| Closed | -$1.06M | – | 1137 |
|
2023
Q4 | $1.06M | Buy |
32,578
+22,548
| +225% | +$732K | 0.1% | 363 |
|
2023
Q3 | $273K | Sell |
10,030
-13,320
| -57% | -$363K | 0.03% | 747 |
|
2023
Q2 | $520K | Buy |
23,350
+3,910
| +20% | +$87K | 0.09% | 421 |
|
2023
Q1 | $421K | Sell |
19,440
-44,688
| -70% | -$968K | 0.08% | 489 |
|
2022
Q4 | $1.3M | Buy |
64,128
+27,211
| +74% | +$553K | 0.31% | 48 |
|
2022
Q3 | $947K | Buy |
36,917
+17,875
| +94% | +$459K | 0.22% | 139 |
|
2022
Q2 | $453K | Sell |
19,042
-34,458
| -64% | -$820K | 0.12% | 310 |
|
2022
Q1 | $1.21M | Buy |
+53,500
| New | +$1.21M | 0.32% | 52 |
|
2021
Q4 | – | Sell |
-16,200
| Closed | -$319K | – | 640 |
|
2021
Q3 | $319K | Buy |
16,200
+1,550
| +11% | +$30.5K | 0.1% | 358 |
|
2021
Q2 | $322K | Buy |
14,650
+2,950
| +25% | +$64.8K | 0.13% | 299 |
|
2021
Q1 | $278K | Buy |
+11,700
| New | +$278K | 0.17% | 251 |
|
2020
Q4 | – | Sell |
-29,487
| Closed | -$513K | – | 440 |
|
2020
Q3 | $513K | Buy |
+29,487
| New | +$513K | 0.38% | 68 |
|
2020
Q1 | – | Sell |
-64,508
| Closed | -$781K | – | 127 |
|
2019
Q4 | $781K | Buy |
+64,508
| New | +$781K | 0.24% | 97 |
|
2017
Q4 | – | Sell |
-23,300
| Closed | -$450K | – | 411 |
|
2017
Q3 | $450K | Buy |
23,300
+8,770
| +60% | +$169K | 0.36% | 76 |
|
2017
Q2 | $171K | Sell |
14,530
-83
| -0.6% | -$977 | 0.16% | 283 |
|
2017
Q1 | $160K | Sell |
14,613
-1,498
| -9% | -$16.4K | 0.41% | 119 |
|
2016
Q4 | $117K | Sell |
16,111
-5,335
| -25% | -$38.7K | 0.36% | 116 |
|
2016
Q3 | $139K | Buy |
21,446
+5,652
| +36% | +$36.6K | 0.37% | 118 |
|
2016
Q2 | $86K | Buy |
+15,794
| New | +$86K | 0.43% | 78 |
|